title: Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?
authors.affiliation: Department of Stroke Medicine, Morriston Hospital, Morriston, Swansea SA6 6NL. mushtaq.wani@swansea-tr.wales.nhs.uk
authors.forename: Mushtaq
authors.initials: M
authors.lastname: Wani
authors.forename: Emma
authors.initials: E
authors.lastname: Nga
authors.forename: Ranjini
authors.initials: R
authors.lastname: Navaratnasingham
mesh_terms: D000925:Anticoagulants; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000000981:diagnostic imaging; D000075202:Contraindications; D003657:Decision Making; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors